Antiviral drugs for treatment of arenavirus infection
AssigneeSiga Technologies, Inc.
InventorsDennis E. Hruby, Tove C. Bolken, Sean Amberg, Dongcheng Dai
Life of this patent
Estimating the term…
Loading patent…
AssigneeSiga Technologies, Inc.
InventorsDennis E. Hruby, Tove C. Bolken, Sean Amberg, Dongcheng Dai
Estimating the term…
Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by hemorrhagic fever viruses is disclosed, i.e., including but not limited to, Arenaviridae (Junin, Machupo, Guanarito, Sabia, Lassa, Tacaribe, and Pichinde), Filoviridae (Ebola and Marburg viruses), Flaviviridae (yellow fever, Omsk hemorrhagic fever and Kyasanur Forest disease viruses), and Bunyaviridae (Rift Valley fever).
A method for the treatment of an Arenavirus infection or disease associated therewith, comprising administering in a therapeutically effective amount to a mammal in need thereof, a compound of Formula I below:
A method for the treatment an Arenavirus infection or disease associated therewith, comprising administering in a therapeutically effective amount to a mammal in need thereof, a compound of Formula I below:
Dependencies are inferred from the claim text.